4.6 Article

De novo SMARCA2 variants clustered outside the helicase domain cause a new recognizable syndrome with intellectual disability and blepharophimosis distinct from Nicolaides-Baraitser syndrome

期刊

GENETICS IN MEDICINE
卷 22, 期 11, 页码 1838-1850

出版社

ELSEVIER SCIENCE INC
DOI: 10.1038/s41436-020-0898-y

关键词

SMARCA2; Nicolaides-Baraitser syndrome; BIS; intellectual disability; neurodevelopmental disorder

资金

  1. Telethon Foundation
  2. Telethon Undiagnosed Diseases Program (TUDP) [GSP15001]
  3. FEDER
  4. Czech Ministry of Health [17-29423A, 00064203]
  5. French Medical Foundation (FRM)
  6. French Medical Foundation
  7. French National Research Agency [ANR-10-LABX-49-01 GRAL, ANR-18-CE18-007]
  8. Wellcome Trust [209568/Z/17/Z, HICF-1009-003]
  9. Department of Health [HICF-1009-003]
  10. Wellcome Trust Sanger Institute [WT098051]
  11. National Institute for Health Research (NIHR) England
  12. NHS England
  13. Finovi
  14. Wellcome Trust [209568/Z/17/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

Purpose Nontruncating variants inSMARCA2, encoding a catalytic subunit of SWI/SNF chromatin remodeling complex, cause Nicolaides-Baraitser syndrome (NCBRS), a condition with intellectual disability and multiple congenital anomalies. Other disorders due toSMARCA2are unknown. Methods By next-generation sequencing, we identified candidate variants inSMARCA2in 20 individuals from 18 families with a syndromic neurodevelopmental disorder not consistent with NCBRS. To stratify variant interpretation, we functionally analyzedSMARCA2variants in yeasts and performed transcriptomic and genome methylation analyses on blood leukocytes. Results Of 20 individuals, 14 showed a recognizable phenotype with recurrent features including epicanthal folds, blepharophimosis, and downturned nasal tip along with variable degree of intellectual disability (or blepharophimosis intellectual disability syndrome [BIS]). In contrast to most NCBRS variants, allSMARCA2variants associated with BIS are localized outside the helicase domains. Yeast phenotype assays differentiated NCBRS from non-NCBRSSMARCA2variants. Transcriptomic and DNA methylation signatures differentiated NCBRS from BIS and those with nonspecific phenotype. In the remaining six individuals with nonspecific dysmorphic features, clinical and molecular data did not permit variant reclassification. Conclusion We identified a novel recognizable syndrome named BIS associated with clustered de novoSMARCA2variants outside the helicase domains, phenotypically and molecularly distinct from NCBRS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据